Similar articles for PMID: 26982462

Year	Number of Results
2001	1
2006	2
2007	8
2008	2
2009	5
2010	6
2011	14
2012	8
2013	14
2014	18
2015	24
2016	15
2017	9
2018	11
2019	17
2020	17
2021	4
2022	1
2024	0

1

Dengue vaccine: an update on recombinant subunit strategies.

Martin J, Hermida L. Martin J, et al. Acta Virol. 2016 Mar;60(1):3-14. doi: 10.4149/av_2016_01_3. Acta Virol. 2016. PMID: 26982462 Review.

2

Recent Developments in Recombinant Protein-Based Dengue Vaccines.

Tripathi NK, Shrivastava A. Tripathi NK, et al. Front Immunol. 2018 Aug 23;9:1919. doi: 10.3389/fimmu.2018.01919. eCollection 2018. Front Immunol. 2018. PMID: 30190720 Free PMC article. Review.

3

Recombinant vesicular stomatitis virus-based dengue-2 vaccine candidate induces humoral response and protects mice against lethal infection.

Lauretti F, Chattopadhyay A, de Oliveira França RF, Castro-Jorge L, Rose J, Fonseca BA. Lauretti F, et al. Hum Vaccin Immunother. 2016 Sep;12(9):2327-33. doi: 10.1080/21645515.2016.1183857. Epub 2016 May 16. Hum Vaccin Immunother. 2016. PMID: 27185081 Free PMC article.

4

Advances in dengue vaccine development.

Raviprakash K, Defang G, Burgess T, Porter K. Raviprakash K, et al. Hum Vaccin. 2009 Aug;5(8):520-8. doi: 10.4161/hv.5.8.9008. Epub 2009 Aug 13. Hum Vaccin. 2009. PMID: 19535912 Review.

5

Dengue vaccine development by the year 2020: challenges and prospects.

Wilder-Smith A. Wilder-Smith A. Curr Opin Virol. 2020 Aug;43:71-78. doi: 10.1016/j.coviro.2020.09.004. Epub 2020 Oct 18. Curr Opin Virol. 2020. PMID: 33086187 Free PMC article. Review.

6

The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced disease.

Coller BA, Clements DE, Bett AJ, Sagar SL, Ter Meulen JH. Coller BA, et al. Vaccine. 2011 Sep 23;29(42):7267-75. doi: 10.1016/j.vaccine.2011.07.021. Epub 2011 Jul 21. Vaccine. 2011. PMID: 21777637 Free PMC article. Review.

7

Elaboration of tetravalent antibody responses against dengue viruses using a subunit vaccine comprised of a single consensus dengue envelope sequence.

Sun J, Li M, Wang Y, Hao P, Jin X. Sun J, et al. Vaccine. 2017 Nov 1;35(46):6308-6320. doi: 10.1016/j.vaccine.2017.09.063. Epub 2017 Oct 4. Vaccine. 2017. PMID: 28987441

8

Evaluation in mice of the immunogenicity and protective efficacy of a tetravalent subunit vaccine candidate against dengue virus.

Lazo L, Izquierdo A, Suzarte E, Gil L, Valdés I, Marcos E, Álvarez M, Romero Y, Guzmán MG, Guillén G, Hermida Cruz L. Lazo L, et al. Microbiol Immunol. 2014 Apr;58(4):219-26. doi: 10.1111/1348-0421.12140. Microbiol Immunol. 2014. PMID: 24689365 Free article.

9

A molecular evaluation of dengue virus pathogenesis and its latest vaccine strategies.

Faheem M, Raheel U, Riaz MN, Kanwal N, Javed F, us Sahar Sadaf Zaidi N, Qadri I. Faheem M, et al. Mol Biol Rep. 2011 Aug;38(6):3731-40. doi: 10.1007/s11033-010-0488-1. Epub 2010 Nov 24. Mol Biol Rep. 2011. PMID: 21107723 Review.

10

Current progress in dengue vaccines.

Wan SW, Lin CF, Wang S, Chen YH, Yeh TM, Liu HS, Anderson R, Lin YS. Wan SW, et al. J Biomed Sci. 2013 Jun 13;20(1):37. doi: 10.1186/1423-0127-20-37. J Biomed Sci. 2013. PMID: 23758699 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

158 results

Results by year